Application
FAM86B1 Antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human bladder carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the FAM86B1 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.Application
FAM86B1 Antibody (C-term) western blot analysis in MCF-7 ,MDA-MB453 cell line lysates (35ug/lane).This demonstrates the FAM86B1 antibody detected the FAM86B1 protein (arrow).| Product Name | FAM86B1 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | FAM86B1; Protein FAM86B1 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | IHCWB |
| IHC:1:50~100 WB |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | FAM86B1 Protein FAM86B1 |
|---|---|
| Molecular Weight(MW) | 32865 Da |
| Tissue Specificity | This FAM86B1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 266-296 amino acids from the C-terminal region of human FAM86B1. |
| Entrez Gene | 85002 |
|---|---|
| Nucleotide Accession | NP_001077006.1 |
Application
FAM86B1 Antibody (C-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human bladder carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the FAM86B1 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.
Application
FAM86B1 Antibody (C-term) western blot analysis in MCF-7 ,MDA-MB453 cell line lysates (35ug/lane).This demonstrates the FAM86B1 antibody detected the FAM86B1 protein (arrow).| Application Notes | IHC:1:50~100 WB |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
